NO20080106L - Opplosning for vevsadhesjonsforhindring og fremgangsmate for vevsadhesjonsforhindring - Google Patents

Opplosning for vevsadhesjonsforhindring og fremgangsmate for vevsadhesjonsforhindring

Info

Publication number
NO20080106L
NO20080106L NO20080106A NO20080106A NO20080106L NO 20080106 L NO20080106 L NO 20080106L NO 20080106 A NO20080106 A NO 20080106A NO 20080106 A NO20080106 A NO 20080106A NO 20080106 L NO20080106 L NO 20080106L
Authority
NO
Norway
Prior art keywords
tissue adhesion
formulation
adhesion prevention
agent
mucopolysaccharide
Prior art date
Application number
NO20080106A
Other languages
English (en)
Inventor
Shigeki Suzuki
Yoshikatsu Miwa
Nobuo Sasaki
Yuichi Tei
Original Assignee
Universtity Of Tokyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universtity Of Tokyo filed Critical Universtity Of Tokyo
Publication of NO20080106L publication Critical patent/NO20080106L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Det er ment å tilveiebringe en væske for forhindring av vevsadhesjon som er lett å anvende på grunn av stabiliteten til tildekningstilstand under en operasjon og generelt anvendbar for en kirurgisk operasjon, og en fremgangsmåte for forhindring av vevsadhesjon. Væsken for forhindring av vevsadhesjon inneholder trehalose som en aktiv bestanddel, og inneholder videre minst én bestanddel av en antioksidant, et kelateringsmiddel, et steriliseringsmiddel, et hemostatisk middel, et antiflogistisk middel, og et polysakkarid, et mukopolysakkarid, et salt av et polysakkarid og et salt av et mukopolysakkarid med en smøreegenskap. Væsken for forhindring av vevsadhesjon er tilveiebrakt i hvilken som helst formulering av et perfusat, en sprøytevæske, en væskeformulering for aerosolisert eller forstøvet administrering, en aerosolskumformulering, en injiserbar formulering som skal tilsettes til en infusjonsformulering, og en infusjonsformulering.
NO20080106A 2005-06-08 2008-01-07 Opplosning for vevsadhesjonsforhindring og fremgangsmate for vevsadhesjonsforhindring NO20080106L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005168744 2005-06-08
PCT/JP2006/311501 WO2006132310A1 (ja) 2005-06-08 2006-06-08 組織癒着防止液及び組織癒着防止方法

Publications (1)

Publication Number Publication Date
NO20080106L true NO20080106L (no) 2008-01-07

Family

ID=37498506

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080106A NO20080106L (no) 2005-06-08 2008-01-07 Opplosning for vevsadhesjonsforhindring og fremgangsmate for vevsadhesjonsforhindring

Country Status (22)

Country Link
US (2) US20090098061A1 (no)
EP (1) EP1905443B1 (no)
JP (1) JP4447640B2 (no)
KR (1) KR101004551B1 (no)
CN (1) CN101193645B (no)
AU (1) AU2006256084B2 (no)
BR (1) BRPI0610889A8 (no)
CA (1) CA2611441C (no)
CY (1) CY1111453T1 (no)
DE (1) DE602006018936D1 (no)
DK (1) DK1905443T3 (no)
ES (1) ES2363674T3 (no)
HR (1) HRP20110150T1 (no)
MY (1) MY142987A (no)
NO (1) NO20080106L (no)
NZ (1) NZ564399A (no)
PL (1) PL1905443T3 (no)
PT (1) PT1905443E (no)
RU (1) RU2395287C2 (no)
SI (1) SI1905443T1 (no)
TW (1) TWI340645B (no)
WO (1) WO2006132310A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142987A (en) * 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
CN101646442B (zh) * 2007-02-23 2013-09-04 21世纪国际新技术株式会社 血管痉挛的治疗剂或预防剂
JP5340823B2 (ja) * 2008-06-24 2013-11-13 ナガセ医薬品株式会社 医療用潤滑剤
KR101062068B1 (ko) * 2008-12-01 2011-09-02 포항공과대학교 산학협력단 유착방지용 조성물
US9119897B2 (en) 2009-05-28 2015-09-01 Profibrix B.V. Dry powder fibrin sealant
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
JP5685751B2 (ja) * 2009-08-04 2015-03-18 国立大学法人弘前大学 結膜下線維芽細胞増殖抑制剤および結膜下線維芽細胞増殖抑制方法
SG180307A1 (en) 2009-09-03 2012-06-28 Hayashibara Biochem Lab Powder containing anhydrous crystals of 2-o-a-d-glucosyl-l-ascorbic acid, manufacturing method therefor, and use thereof
WO2012033218A1 (ja) 2010-09-07 2012-03-15 株式会社林原生物化学研究所 ２−Ｏ−α−Ｄ−グルコシル−Ｌ−アスコルビン酸含水結晶及び２−Ｏ−α−Ｄ−グルコシル−Ｌ−アスコルビン酸含水結晶含有粉末とそれらの製造方法並びに用途
CN106220696B (zh) 2011-03-07 2019-12-24 株式会社林原 含有2-O-α-D-葡萄糖基-L-抗坏血酸无水结晶的粉末的制造方法
CN106390186B (zh) 2011-04-27 2020-07-03 比奥马普公司 止血组合物
WO2013112381A2 (en) 2012-01-24 2013-08-01 Bvw Holding Ag New class of anti-adhesion hydrogels with healing aspects
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy
JP6837835B2 (ja) 2013-05-07 2021-03-03 バイオ・ブラスト・ファーマ・リミテッドＢｉｏ Ｂｌａｓｔ Ｐｈａｒｍａ Ｌｔｄ． トレハロースの非経口投与によるタンパク質凝集ミオパシーおよび神経変性疾患の治療
CN104107189B (zh) * 2014-06-20 2016-08-31 天津嘉氏堂科技有限公司 皮肤护理组合物及其制剂
CN104027341B (zh) * 2014-06-20 2016-08-31 天津嘉氏堂科技有限公司 一种皮肤护理组合物及其制剂
CN104013639B (zh) * 2014-06-20 2016-08-31 天津嘉氏堂科技有限公司 一种具有皮肤修护功能的组合物及其凝胶剂
CN104257682B (zh) * 2014-10-28 2016-04-27 天津嘉氏堂科技有限公司 一种创面修护组合物及制剂
CN104382931B (zh) * 2014-10-28 2017-06-13 天津嘉氏堂科技有限公司 皮肤创面护理组合物
CN104257687B (zh) * 2014-10-28 2017-02-15 天津嘉氏堂科技有限公司 用于治疗皮肤创伤的组合物及其糊剂
FR3036044B1 (fr) * 2015-05-13 2021-04-30 Cha Ling Dispositif de pulverisation de molecules non volatiles et/ou instables a la temperature, methode de pulverisation associee
CN105168211B (zh) * 2015-10-13 2016-11-16 重庆华森制药股份有限公司 一种奥美拉唑钠药物组合物
WO2017082121A1 (ja) * 2015-11-12 2017-05-18 テルモ株式会社 徐放性局所投与剤
WO2017149584A1 (ja) 2016-02-29 2017-09-08 川澄化学工業株式会社 癒着防止材
CN110087705B (zh) 2016-05-03 2022-08-05 Bvw控股公司 多相凝胶
ES2882506T3 (es) 2016-08-12 2021-12-02 Biomup France Sas Fluido hemostático
WO2019044765A1 (ja) * 2017-08-28 2019-03-07 川澄化学工業株式会社 癒着防止材
KR102039552B1 (ko) * 2017-10-23 2019-11-01 이재혁 상처 부위에 도포되는 발포성 밴드
IL276693B2 (en) 2018-02-15 2023-11-01 Biomup France Sas Multi-dimensional hemostatic product and method for producing the same
KR102427018B1 (ko) * 2019-06-11 2022-07-29 재단법인 베스티안재단 피부치료제의 제조방법 및 이로부터 얻어지는 피부치료제
JP2022550570A (ja) 2019-10-01 2022-12-02 シーロス セラピューティクス， インコーポレイテッド トレハロース製剤およびその使用
WO2024014443A1 (ja) * 2022-07-12 2024-01-18 株式会社大塚製薬工場 カプセル化膵島の保存用又は移植用液
WO2025163775A1 (ja) * 2024-01-31 2025-08-07 カルテック株式会社 加湿器の水の添加剤

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
JP2948254B2 (ja) 1990-03-06 1999-09-13 ユニチカ株式会社 癒着防止材
BR9305768A (pt) * 1992-01-22 1997-01-28 Novo Nordisk As Fator XIII ativado composiçao e processo para a produçao do fator XIII ativado
JP3572085B2 (ja) 1992-07-10 2004-09-29 味の素ファルマ株式会社 栄養輸液剤
JP3253131B2 (ja) 1992-07-24 2002-02-04 洋巳 和田 移植臓器用溶液
JP3418423B2 (ja) 1993-03-03 2003-06-23 久光製薬株式会社 経粘膜投与用薬剤組成物
JPH06319486A (ja) 1993-03-16 1994-11-22 Hayashibara Biochem Lab Inc エネルギー用糖源とその用途
JP3420851B2 (ja) 1994-12-06 2003-06-30 株式会社資生堂 癒着防止剤
JP4033510B2 (ja) 1995-12-27 2008-01-16 ロート製薬株式会社 トレハロースを含有する眼科用医薬組成物
JP2868206B2 (ja) * 1996-04-16 1999-03-10 株式会社オフテクス 消毒および／または防腐のための有害微生物防除用組成物
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
WO1997047192A1 (en) * 1996-06-14 1997-12-18 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
NZ333030A (en) * 1996-06-14 2000-05-26 Biostore Nz Ltd Compositions comprising solutes selected from raffinose, trehalose, trimethyl amine oxide and betaine, and use for the preservation of living tissues
US6020367A (en) * 1997-12-02 2000-02-01 Avon Products, Inc. Supersaturated ascorbic acid solutions
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US6365338B1 (en) * 1999-04-27 2002-04-02 David A. Bull Organ preservative solution containing trehalose, anti-oxidant, cations and an energy source
KR20020010920A (ko) * 1999-06-02 2002-02-06 추후제출 각질세포 성장 인자-2 제제
JP2002024832A (ja) 2000-06-30 2002-01-25 Koboruto:Kk 指紋データの管理方法および装置
US6653062B1 (en) * 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
JP2002047189A (ja) 2000-07-26 2002-02-12 Seishi Yoneda 心停止液
US20040047892A1 (en) * 2000-11-15 2004-03-11 Desrosiers Eric Andre Filler composition for soft tissue augmentation and reconstructive surgery
US20060134140A1 (en) * 2001-04-12 2006-06-22 Dana Lasko Compositions and methods for treating tumor spreading
JP4286480B2 (ja) * 2001-09-17 2009-07-01 株式会社メニコン 殺菌液
WO2003070110A1 (en) * 2002-02-20 2003-08-28 New X-National Technology K.K. Drug administration method
WO2003101460A1 (en) * 2002-06-03 2003-12-11 Cac Corporation External preparations for treating dermatitis
JP2004224677A (ja) * 2003-01-20 2004-08-12 Masahiro Nagahama 抗線虫及び病害虫等による食害軽減効果と抗ウイルス効果とを有する肥料組成物
JP4904811B2 (ja) * 2003-02-13 2012-03-28 株式会社林原生物化学研究所 α，α−トレハロースの糖質誘導体を含有することを特徴とする皮膚外用剤
JPWO2004076602A1 (ja) * 2003-02-27 2006-06-08 株式会社林原生物化学研究所 脂質膜を構成している脂質の分解抑制方法及びその用途
EP1624751A2 (en) * 2003-05-08 2006-02-15 Cellartis AB Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
FR2855177B1 (fr) 2003-05-23 2005-07-08 Raymond Robert Composition contenant des acides nucleiques lyophilises en presence de collagene et de disaccharides
KR20060033723A (ko) 2003-06-05 2006-04-19 카아길, 인코포레이팃드 트레할로스와 단백질의 음료 첨가제 혼합물
EP1745747A4 (en) 2004-05-13 2010-12-29 Next21 Kk Apparatus for hemostasis and adhesion prevention for use in endoscopic surgery
US7433759B2 (en) * 2004-07-22 2008-10-07 Applied Materials, Inc. Apparatus and methods for positioning wafers
US20060047005A1 (en) * 2004-08-26 2006-03-02 Salamone Joseph C Compositions containing N,N,N',N'-tetrakis(hydroxyalkyl)diamine-or N,N,N',N'-tetrakis(hydroxyalkoxy)diamine-based buffers
JP2006188672A (ja) * 2004-12-06 2006-07-20 Hayashibara Biochem Lab Inc ラジカル生成抑制剤
MY142987A (en) * 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention

Also Published As

Publication number Publication date
BRPI0610889A2 (pt) 2010-08-03
NZ564399A (en) 2010-09-30
AU2006256084B2 (en) 2010-01-28
EP1905443B1 (en) 2010-12-15
CA2611441C (en) 2012-03-06
US20090098061A1 (en) 2009-04-16
KR101004551B1 (ko) 2011-01-03
KR20080019054A (ko) 2008-02-29
TWI340645B (en) 2011-04-21
PT1905443E (pt) 2011-03-07
US20110166089A1 (en) 2011-07-07
TW200722094A (en) 2007-06-16
AU2006256084A1 (en) 2006-12-14
PL1905443T3 (pl) 2011-05-31
RU2395287C2 (ru) 2010-07-27
CN101193645B (zh) 2010-12-08
DE602006018936D1 (de) 2011-01-27
BRPI0610889A8 (pt) 2017-01-24
WO2006132310A1 (ja) 2006-12-14
CN101193645A (zh) 2008-06-04
SI1905443T1 (sl) 2011-04-29
EP1905443A1 (en) 2008-04-02
ES2363674T3 (es) 2011-08-11
RU2007149561A (ru) 2009-07-20
HK1113746A1 (en) 2008-10-17
US9155751B2 (en) 2015-10-13
JPWO2006132310A1 (ja) 2009-01-08
EP1905443A4 (en) 2009-12-16
DK1905443T3 (da) 2011-03-28
JP4447640B2 (ja) 2010-04-07
CA2611441A1 (en) 2006-12-14
HRP20110150T1 (hr) 2011-04-30
CY1111453T1 (el) 2015-08-05
MY142987A (en) 2011-02-14

Similar Documents

Publication Publication Date Title
TW200722094A (en) Solution for tissue adhesion prevention and method for tissue adhesion prevention
WO2008138936A3 (de) Zerstäuber und filter
MX386614B (es) Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
EP2607348A3 (en) Plasminogen Activator Inhibitor-1 Inhibitor
Maier et al. Safety assessment for ethanol-based topical antiseptic use by health care workers: evaluation of developmental toxicity potential
WO2006129161A3 (en) Vitamin formulation
WO2009129464A3 (en) Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
WO2008108491A1 (ja) 有害生物防除用組成物
HRP20110451T1 (hr) Upotreba izotiocijanata kao sredstva protiv mieloma
BR112018010234A2 (pt) spray formador de película tópica
NO20053577L (no) Clindamycin phosphate foam
WO2007105203A3 (en) Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
BR112015005047A2 (pt) dispositivo e conjunto de ponta sem ar à prova de entupimento
WO2011051924A3 (en) Method of wound treatment using liquid gallium nitrate
WO2008136034A3 (en) Ophthalmic compositions for the treatment of ocular hypertension and glaucoma
WO2007070561A3 (en) Agents for controlling biological fluids and methods of use thereof
IL273329A (en) Modulation of hepatic-hepatic epidermal growth factor activity to heal the eardrum membrane
EP1774968A4 (en) BENYLISOCHINOLINE DERIVATIVE OR BISBENZYLISOCHINOLINE DERIVATIVE PSYCHOTROPES AGENT, ANALGETICS AND / OR ANTIPHLOGISTIC AND FOOD TO PROMOTE HEALTH
WO2008114376A1 (ja) メラニン生成抑制組成物
BR112022002280A2 (pt) Composição para controlar deriva de pulverização, composição aquosa, método para reduzir deriva de pulverização, uso da composição aquosa, e, kit de peças
WO2012106058A3 (en) Animal treatments
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
WO2009061152A3 (en) Composition for prevention and treatment of pain containing curcumin or pharmaceutically acceptable salt thereof as an active ingredient
MX2007015381A (es) Liquido para evitar adhesion de tejido y metodo para evitar adhesion de tejido.
WO2008099906A1 (ja) 歯周病、及び外科手術による歯槽骨欠損の治療剤

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application